Researchers identify powerful pain reliever
A team of scientists have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway...
List view / Grid view
A team of scientists have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway...
A collaborative team of scientists have developed a novel synthetic vaccine with a method grown in plants that uses virus-like particles...
Researchers have shown that catching and treating breast cancer before it spreads is now a realistic goal...
Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1...
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
Researchers have discovered a trove of neuronal subtypes and gene regulators, using a new method they developed called snmC-seq...
Scientists have identified a Par-4 amino-terminal fragment that is released by diverse therapy-sensitive cancer cells...
A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
A report published has identified the prospects of immunotherapy treatments...
Scientists have made progress in the development of products that improve mitochondrial function...
Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
The European Research Council has announced its 2018 grant competitions with a total budget of around €1.86bn...
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
A protein has been identified as a possible cause for the adverse reaction of the immune system in patients suffering from lupus.